TY - JOUR
T1 - Distinguishing Between Cachexia, Sarcopenia and Protein Energy Wasting in End-Stage Renal Disease Patients on Dialysis
AU - Slee, Adrian
PY - 2016/11/25
Y1 - 2016/11/25
N2 - Patients with end-stage renal disease (ESRD) receiving dialysis can have altered
nutritional status and body composition due to dietary restrictions, level of physical activity,
co-morbidities, metabolic alterations and inflammation.1
As such, weight loss or wasting is
common among this population with up to 75% of adults with ESRD undergoing maintenance
dialysis displaying some evidence of wasting.2
There are several forms of loss of lean muscle
mass or wasting in ESRD, including ‘protein energy wasting’, ‘cachexia’, and ‘age-related
sarcopenia’ and these terms are often used interchangeably alongside ‘malnutrition’ in current
care. Limited understanding of the differences between such terms is arguably a barrier to accurate recognition and management of these disorders in patients with ESRD. For instance, a
recent European study of over 700 dietetic participants concluded that only 13% of health care
professionals who could differentiate between malnutrition, starvation, cachexia and sarcopenia.3
Such knowledge is pertinent as for example, loss of muscle mass is a key feature in both
sarcopenia and cachexia, but most patients with sarcopenia are not cachectic,4
as muscle wasting occurs with aging
AB - Patients with end-stage renal disease (ESRD) receiving dialysis can have altered
nutritional status and body composition due to dietary restrictions, level of physical activity,
co-morbidities, metabolic alterations and inflammation.1
As such, weight loss or wasting is
common among this population with up to 75% of adults with ESRD undergoing maintenance
dialysis displaying some evidence of wasting.2
There are several forms of loss of lean muscle
mass or wasting in ESRD, including ‘protein energy wasting’, ‘cachexia’, and ‘age-related
sarcopenia’ and these terms are often used interchangeably alongside ‘malnutrition’ in current
care. Limited understanding of the differences between such terms is arguably a barrier to accurate recognition and management of these disorders in patients with ESRD. For instance, a
recent European study of over 700 dietetic participants concluded that only 13% of health care
professionals who could differentiate between malnutrition, starvation, cachexia and sarcopenia.3
Such knowledge is pertinent as for example, loss of muscle mass is a key feature in both
sarcopenia and cachexia, but most patients with sarcopenia are not cachectic,4
as muscle wasting occurs with aging
U2 - 10.17140/PMHCOJ-2-e004
DO - 10.17140/PMHCOJ-2-e004
M3 - Article
SN - 2377-8393
SP - 11
EP - 13
JO - Palliative Medicine and Hospice Care
JF - Palliative Medicine and Hospice Care
ER -